Updated assessment of the six-minute walk test as predictor of acute radiation-induced pneumonitis

International Journal of Radiation Oncology Biology Physics

Volumn 67, Issue 3, 2007, Pages 759-767

  Mao, Jingfang ^a,c   Zhang, Junan ^a   Zhou, Sumin ^a   Das, Shiva ^a   Hollis, Donna R ^a   Folz, Rodney J ^b   Wong, Terence Z ^a   Marks, Lawrence B ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Allergy   (United States)

^c FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

Author keywords

Acute radiation induced pneumonitis; Dosimetric parameters; Pulmonary function tests; Receiver operating characteristics; Six minute walk test

Indexed keywords

BIOLOGICAL RADIATION EFFECTS; BIOMECHANICS; COMPUTER SOFTWARE; DOSIMETRY; TUMORS;

ACUTE RADIATION-INDUCED PNEUMONITIS; DOSIMETRIC PARAMETERS; PULMONARY FUNCTION TESTS; RECEIVER OPERATING CHARACTERISTICS; SIX-MINUTE WALK TEST;

RADIOTHERAPY;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPUTER PROGRAM; CORRELATION COEFFICIENT; DISEASE SEVERITY; DOSIMETRY; EXERCISE TEST; FEMALE; FOLLOW UP; HUMAN; LUNG FUNCTION TEST; LUNG TUMOR; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION INDUCED PNEUMONITIS; RECEIVER OPERATING CHARACTERISTIC; SIX MINUTE WALK TEST;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; EXERCISE TEST; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIATION PNEUMONITIS; REGRESSION ANALYSIS; RESPIRATORY FUNCTION TESTS; ROC CURVE;

EID: 33846811292     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.10.001     Document Type: Article

References (52)

1. Fay M., Tan A., Fisher R., et al. Dose-volume histogram analysis as predictor of radiation pneumonitis in primary lung cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 61 (2005) 1355-1363
2. Kocak Z., Yu X., Zhou S.M., et al. The impact of pre-radiotherapy surgery on radiation-induced lung injury. Clin Oncol (R Coll Radiol) 17 (2005) 210-216
3. Kwa S.L., Lebesque J.V., Theuws J.C., et al. Radiation pneumonitis as a function of mean lung dose: An analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys 42 (1998) 1-9
4. Schraube P., Schell R., Wannenmacher M., et al. Pneumonitis after radiotherapy of bronchial carcinoma: incidence and influencing factors. Strahlenther Onkol 173 (1997) 369-378
5. Armstrong J.G., Zelefsky M.J., Leibel S.A., et al. Strategy for dose escalation using 3-dimensional conformal radiation therapy for lung cancer. Ann Oncol 6 (1995) 693-697
6. Claude L., Perol D., Ginestet C., et al. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: Clinical and dosimetric factors analysis. Radiother Oncol 71 (2004) 175-181
7. Graham M.V., Purdy J.A., Emami B., et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small-cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 45 (1999) 323-329
8. Hernando M.L., Marks L.B., Bentel G.C., et al. Radiation-induced pulmonary toxicity: A dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys 51 (2001) 650-659
9. Kim T.H., Cho K.H., Pyo H.R., et al. Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer. Radiology 235 (2005) 208-215
10. Rancati T., Ceresoli G.L., Gagliardi G., et al. Factors predicting radiation pneumonitis in lung cancer patients: A retrospective study. Radiother Oncol 67 (2003) 275-283
11. Tsujino K., Hirota S., Endo M., et al. Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer. Int J Radiat Oncol Biol Phys 55 (2003) 110-115
12. Yorke E.D., Jackson A., Rosenzweig K.E., et al. Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys 54 (2002) 329-339
13. Mao J., Kocak Z., Zhou S., et al. Predicting symptomatic radiation-induced pneumonitis. In: Mehta M., Paliwal B.A., and Bentzen S.M. (Eds). Seventh international conference on dose, time and fractionation in radiation oncology (2005), Medical Physics, Madison, Wisconsin 262-283
14. Lind P.A., Marks L.B., Hollis D., et al. Receiver operating characteristic curves to assess predictors of radiation-induced symptomatic lung injury. Int J Radiat Oncol Biol Phys 54 (2002) 340-347
15. Sunyach M.P., Falchero L., Pommier P., et al. Prospective evaluation of early lung toxicity following three-dimensional conformal radiation therapy in non-small-cell lung cancer: Preliminary results. Int J Radiat Oncol Biol Phys 48 (2000) 459-463
16. Marks L.B., Munley M.T., Bentel G.C., et al. Physical and biological predictors of changes in whole-lung function following thoracic irradiation. Int J Radiat Oncol Biol Phys 39 (1997) 563-570
17. Miller K.L., Kocak Z., Kahn D., et al. Preliminary report of the 6-minute walk test as a predictor of radiation-induced pulmonary toxicity. Int J Radiat Oncol Biol Phys 62 (2005) 1009-1013
18. Garst J., Shafman T., D'Amico T., et al. A phase II trial of neo-adjuvant concurrent carboplatin and vinorelbine chemotherapy with radiation followed by surgical resection in patients with stage IIB/IIIA non-small cell lung cancer. [Abstract]. Proc Am Soc Clin Oncol J Clin Oncol 21 (2002) 318a
19. Socinski M.A., Marks L.B., Garst J., et al. Carboplatin/paclitaxel or carboplatin/vinorelbine followed by accelerated hyperfractionated conformal radiation therapy: A preliminary report of a phase I dose escalation trial from the Carolina Conformal Therapy Consortium. Oncologist 6 Suppl. 1 (2001) 20-24
20. Marks L.B., Garst J., Socinski M.A., et al. Carboplatin/paclitaxel or carboplatin/vinorelbine followed by accelerated hyperfractionated conformal radiation therapy: Report of a prospective phase I dose escalation trial from the Carolina Conformal Therapy Consortium. J Clin Oncol 22 (2004) 4329-4340
21. Anscher M.S., Marks L.B., Shafman T.D., et al. Using plasma transforming growth factor beta-1 during radiotherapy to select patients for dose escalation. J Clin Oncol 19 (2001) 3758-3765
22. Arbuck SG, Ivy SP, Setser A, et al. Common Toxicity Criteria version 2.0. Accessed http://ctep.info.nih.gov 1997.
23. Kocak Z., Evans E.S., Zhou S.M., et al. Challenges in defining radiation pneumonitis in patients with lung cancer. Int J Radiat Oncol Biol Phys 62 (2005) 635-638
24. Choi N.C., and Kanarek D.J. Toxicity of thoracic radiotherapy on pulmonary function in lung cancer. Lung Cancer 10 Suppl. 1 (1994) S219-S230
25. Curran Jr. W.J., Moldofsky P.J., and Solin L.J. Observations on the predictive value of perfusion lung scans on post-irradiation pulmonary function among 210 patients with bronchogenic carcinoma. Int J Radiat Oncol Biol Phys 24 (1992) 31-36
26. De Jaeger K., Seppenwoolde Y., Boersma L.J., et al. Pulmonary function following high-dose radiotherapy of non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 55 (2003) 1331-1340
27. Marks L.B., Hollis D., Munley M., et al. The role of lung perfusion imaging in predicting the direction of radiation-induced changes in pulmonary function tests. Cancer 88 (2000) 2135-2141
28. Marks L.B., Munley M.T., Spencer D.P., et al. Quantification of radiation-induced regional lung injury with perfusion imaging. Int J Radiat Oncol Biol Phys 38 (1997) 399-409
29. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: Guidelines for the six-minute walk test. Am J Respir Crit Care Med 166 (2002) 111-117
30. Olsson L.G., Swedberg K., Clark A.L., et al. Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: A systematic review. Eur Heart J 26 (2005) 778-793
31. Rubim V.S., Drumond Neto C., Romeo J.L., et al. Prognostic value of the six-minute walk test in heart failure. Ar Qbras Cardiol 86 (2006) 120-125
32. Cahalin L.P., Mathier M.A., Semigran M.J., et al. The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure. Chest 110 (1996) 325-332
33. Li A.M., Yin J., Yu C.C., et al. The six-minute walk test in healthy children: Reliability and validity. Eur Respir J 25 (2005) 1057-1060
34. Nixon P.A., Joswiak M.L., and Fricker F.J. A six-minute walk test for assessing exercise tolerance in severely ill children. J Pediatr 129 (1996) 362-366
35. Harada N.D., Chiu V., and Stewart A.L. Mobility-related function in older adults: Assessment with a 6-minute walk test. Arch Phys Med Rehabil 80 (1999) 837-841
36. Bean J.F., Kiely D.K., Leveille S.G., et al. The 6-minute walk test in mobility-limited elders: What is being measured?. J Gerontol A Biol Sci Med Sci 57 (2002) M751-M756
37. Mason R.J., Murray J.F., Broaddus V.C., et al. Murray & Nadel's textbook of respiratory medicine. 4th ed. (2005), WB Saunders, Philadelphia
38. Marin J.M., Carrizo S.J., Gascon M., et al. Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 163 (2001) 1395-1399
39. Chetta A., Aiello M., Foresi A., et al. Relationship between outcome measures of six-minute walk test and baseline lung function in patients with interstitial lung disease. Sarcoidosis Vasc Diffuse Lung Dis 18 (2001) 170-175
40. Enright P.L., McBurnie M.A., Bittner V., et al. The 6-min walk test: A quick measure of functional status in elderly adults. Chest 123 (2003) 387-398
41. Yorke E.D., Jackson A., Rosenzweig K.E., et al. Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study. Int J Radiat Oncol Biol Phys 63 (2005) 672-682
42. Abratt R.P., Willcox P.A., and Smith J.A. Lung cancer in patients with borderline lung functions-Zonal lung perfusion scans at presentation and lung function after high dose irradiation. Radiother Oncol 19 (1990) 317-322
43. Gibbons W.J., Fruchter N., Sloan S., et al. Reference values for a multiple repetition 6-minute walk test in healthy adults older than 20 years. J Cardiopulm Rehabil 21 (2001) 87-93
44. Hamilton D.M., and Haennel R.G. Validity and reliability of the 6-minute walk test in a cardiac rehabilitation population. J Cardiopulm Rehabil 20 (2000) 156-164
45. Miyamoto S., Nagaya N., Satoh T., et al. Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension: Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med 161 (2000) 487-492
46. Ingle L., Reddy P., Clark A.L., et al. Diabetes lowers six-minute walk test performance in heart failure. J Am Coll Cardiol 47 (2006) 1909-1910
47. Wu G., Sanderson B., and Bittner V. The 6-minute walk test: How important is the learning effect?. Am Heart J 146 (2003) 129-133
48. Leach R.M., Davidson A.C., Chinn S., et al. Portable liquid oxygen and exercise ability in severe respiratory disability. Thorax 47 (1992) 781-789
49. Enright P.L. The six-minute walk test. Respir Care 48 (2003) 783-785
50. Lama V.N., Flaherty K.R., Toews G.B., et al. Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 168 (2003) 1084-1090
51. Paciocco G., Martinez F.J., Bossone E., et al. Oxygen desaturation on the six-minute walk test and mortality in untreated primary pulmonary hypertension. Eur Respir J 17 (2001) 647-652
52. Jouven X., Empana J.P., Schwartz P.J., et al. Heart-rate profile during exercise as a predictor of sudden death. N Engl J Med 352 (2005) 1951-1958